Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





Current Intelligence Bulletin 22: Ethylene Thiourea (ETU)										Related Pages
										April 11, 1978
DHHS (NIOSH) Publication Number 78-144

Identifiers and Synonyms for Ethylene Thiourea
Chemical Abstracts Service
Number 96-45-7
NIOSH RTECS Number NI96250
Chemical Formula C3H6N2S
4,5-Dihydroimidazole-2(3H)-thione
4,5-Dihydro-2-mercaptoimidazole
N,N’-(1,2-Ethanediyl)thiourea
Ethylene thiourea
Ethylenethiourea
1,3-Ethylene-2-thiourea
1,3-Ethylenethiourea
N,N’-Ethylenethiourea
ETU
Imidazolidinethione
Imidazoline-2-thiol
2-Imidazolidinethione
2-Imidazoline-2-thiol
Imidazoline-2(3H)-thione
Mercaptoimidazoline
2-Mercaptoimidazoline
2-Mercapto-2-imidazoline
NA 22
NA-22-D
Pennac CRA
Rhodanin S 62
Sodium-22 Neoprene accelerator
Tetrahydro-2H-imidazole-2-thione
2-Thiol-dihydroglyoxaline
Warecure C

Ethylene Thiourea (ETU)
The National Institute for Occupational Safety and Health (NIOSH) recommends that ethylene thiourea be handled in the workplace as if it were a human carcinogen and teratogen. During development of a NIOSH Special Occupational Hazard Review on ethylene thiourea (scheduled for issuance later in 1978) it became apparent that exposure to ethylene thiourea poses a risk of teratogenesis, particularly to the central nervous system, which is greater than has been generally recognized. The NIOSH literature review clearly shows ethylene thiourea to be a teratogen and a carcinogen in laboratory rats with supportive studies in other species. Pending completion of a NIOSH Special Occupational Hazard Review, this Current Intelligence Bulletin has been prepared to provide early dissemination of the information since NIOSH believes it would be prudent to minimize occupational exposure to ethylene thiourea. There is no current Occupational Safety and Health Administration (OSHA) exposure standard for ethylene thiourea.

Background
Ethylene thiourea is a white crystalline solid which is used extensively as an accelerator in the curing of polychloroprene (Neoprene) and other elastomers. NIOSH estimates that approximately 3,500 workers in the rubber industry have potential occupational exposure to ethylene thiourea. This estimate is based on the NIOSH National Occupational Hazard Survey which was conducted between 1972 and 1974, and included over 500,000 employees at 4,775 facilities. In addition, exposure to ethylene thiourea also results from the very widely used ethylene bisdithiocarbamate fungicides. Ethylene thiourea may be present as a contaminant in the ethylene bisdithiocarbamate fungicides and can also be formed when food containing the fungicides is cooked. Commercial ethylene thiourea is available as a solid powder, as a dispersion in oil (which retards the formation of fine dust dispersions in workplace air), and “encapsulated” in a matrix of compatible elastomers. In this latter form, ethylene thiourea may be least likely to escape into the workplace air.

Laboratory Animal Studies
Ethylene thiourea has been shown to be carcinogenic and teratogenic (causing malformations in offspring) in laboratory animals. In addition, ethylene thiourea can cause myxedema (the drying and thickening of skin, together with a slowing down of physical and mental activity), goiter, and other effects related to decreased output of thyroid hormone. In a recent publication from E. I. du Pont de Nemours and Company’s Haskell Laboratory, for example, Stula and Krauss report “marked teratogenic effects were demonstrated” when ethylene thiourea was applied to the skin of laboratory rats.1 In this study, 50 milligrams ethylene thiourea per kilogram body weight was applied as a 20% solution in dimethylsulfoxide (DMSO) to the skin of pregnant, female Sprague-Dawley rats on the twelfth and also on the thirteenth day of gestation. Malformations were observed in all of seventy-three fetuses upon sacrifice of the pregnant females on the twentieth day of gestation. Appropriate control animals showed no fetal abnormality. A number of other reports in the literature further document the teratogenic potential of ethylene thiourea (e.g., 2 and references cited therein).
The Stula and Krauss study1 further demonstrates that dose as well as day of gestation on which exposures occur are critical factors. When 50 mg/kg ethylene thiourea applications were made as above, but on the tenth and eleventh day of gestation, only five of eighty-three fetuses exhibited abnormalities; DMSO controls in this case exhibited one abnormality in forty fetuses. However, no fetal abnormalities were found among pregnant rats similarly exposed to 25 mg/kg ethylene thiourea on the tenth and also on the eleventh day of gestation.
Ethylene thiourea has been shown to cause cancer in laboratory animals. In one study, for example, Charles River CD rats were fed ethylene thiourea at 175 or 350 ppm in their diets for eighteen months and then observed while on a control diet for an additional six months.3 Thyroid carcinomas were observed in seventeen of twenty-six males2 with pulmonary metastases) and eight of twenty-six females at the high dose level, as well as three of twenty-six males and three of twenty-six females at the low dose level. In addition, solid-cell adenomas of the thyroid were observed in one female at the high dose level as well as two females at the low dose level. No thyroid carcinoma was found among the thirty-two male or thirty-two female controls. The International Agency for Research in Cancer (IARC) has concurred that oral administration of ethylene thiourea produces thyroid carcinoma in rats.4 authors5,6 also reported carcinogenic effects of ethylene thiourea in laboratory animals.
A more complete review of animal experiments on ethylene thiourea will be presented in the forthcoming NIOSH Special Occupational Hazard Review.
NIOSH Recommendation
Pending completion of the NIOSH Special Occupational Hazard Review and the development of specific recommended control measures for ethylene thiourea, the National Institute for Occupational Safety and Health recommends, as an interim and prudent measure) that occupational exposure to ethylene thiourea be minimized exposure should be limited to as few employees as possible, while minimizing workplace exposure levels with engineering and work practice controls. Although substitution is a possible control measure, alternatives to ethylene thiourea or ethylene bisdithiocarbarmate fungicides should be fully evaluated with regard to possible human health effects.
*[signature]*
J. Donald Millar, M.D.
Assistant Surgeon General
Acting Director

Suggested Guidelines for Minimizing Employee Exposure to Ethylene Thiourea (ETU)
NIOSH recommends that it would be prudent to handle ethylene thiourea in the workplace as if it were a human carcinogen and teratogen. Exposure to ethylene thiourea should be limited to as few employees as possible) while minimizing workplace exposure levels. The area in which it is used should be restricted to only those employees essential to the process or operation.

Exposure Monitoring
Initial and routine employee exposure surveys should be made by competent industrial hygiene and engineering personnel. These surveys are necessary to determine the extent of employee exposure and to ensure that controls are effective.
The *NIOSH Occupational Exposure Sampling Strategy Manual,* NIOSH Publication #77-173, may be helpful in developing efficient programs to monitor employee exposures to ethylene thiourea. The manual discusses determination of the need for exposure measurements, selection of appropriate employees for exposure evaluation, and selection of sampling times.
Employee exposure measurements should consist of 8-hour TWA (time-weighted average) exposure estimates calculated from personal or breathing zone samples (air that would most nearly represent that inhaled by the employees). Area and source measurements may be useful to determine problem areas, processes, and operations.

Minimizing Employee Exposure
There are four basic methods of limiting employee exposure to ethylene thiourea. None of these is a simple industrial hygiene or management decision and careful planning and thought should be used prior to implementation of any of these.

**Product Substitution**
The substitution of an alternative material with a lower potential health and safety risk is one method. However, extreme care must be used when selecting possible substitutes. Alternatives to ethylene thiourea should be fully evaluated with regard to possible human effects. Unless the toxic effects of the alternative have been thoroughly evaluated, a seemingly safe replacement, possibly only after years of use, may be found to induce serious health effects.
**Contaminant Controls**
The most effective control of ethylene thiourea where feasible, is at the source of contamination by enclosure of the operation and/or local exhaust ventilation. If feasible, the process or operation should be enclosed with a slight vacuum so that any leakage will result in the flow of air into the enclosure. The next most effective means of control would be a well designed local exhaust ventilation system that physically encloses the process as much as possible, with sufficient capture velocity to keep the contaminant from entering the work atmosphere. To ensure that ventilation equipment is working properly, effectiveness (e.g., air velocity static pressure, or air volume) should be checked at least every three months. System effectiveness should be checked soon after any change in production process, or control which might result in significant increases in airborne exposures to ethylene thiourea.
**Employee Isolation**
A third alternative is the isolation of employees. It frequently involves the use of automated equipment operated by personnel observing from a closed control booth or room. The control room is maintained at a greater air pressure than that surrounding the process equipment so that air flow is out of, rather than into, the room. This type of control will not protect those employees that must do process checks, adjustments, maintenance, and related operations.
**Personal Protective Equipment**
The least preferred method is the use of personal protective equipment. This equipment which may include respirators, goggles, gloves, and related items, should not be used as the only means to prevent or minimize exposure during routine operations. Exposure to ethylene thiourea should not be controlled with the use of respirators except:
During the time necessary to install or implement engineering or work practice controls; or
In work situations in which engineering and work practice controls are technically not feasible; or
For maintenance; or
For operations which require entry into tanks or closed vessels; or
In emergencies.Only respirators approved by the National Institute for Occupational Safety and Health (NIOSH) should be used. Refer to *NIOSH Certified Equipment, December 15, 1975,* NIOSH publication #76-145 and *Cumulative Supplement June 1977, NIOSH Certified Equipment,* NIOSH publication #77-195. The use of faceseal coverlets or socks with any respirator voids NIOSH approvals. Quantitative faceseal fit test equipment (such as sodium chloride, dioctyl phthalate, or equivalent) should be used. Refer to *A guide to Industrial Respiratory Protection,* NIOSH publication #76-189 for guidelines on appropriate respiratory protection programs.

References
Stula, E. F. and Krauss, W. C., “Embryotoxicity in Rats and Rabbits from Cutaneous Application of Amide-Type Solvents and Substituted Ureas,” Toxicology and Applied Pharmacology, 41, 35-55, 1977.
Khera, K. S. and Tryphonas, L., “Ethylenethiourea-Induced Hydrocephalus: -and Postnatal Pathogenesis in Offspring from Rats Given a Single Oral Dose during Pregnancy,” Toxicology and Applied Pharmacology, 42, 85-97, 1977.
Ulland, B. M. et al., “Thyroid Cancer in Rats from Ethylene Thiourea Intake,” J. Nat. Cancer Inst., 49, 583-584, 1972.
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, 7, 45-52, 1974.
Innes, J. R. M. et al., “Bioassay of Pesticides and Industrial Chemicals for Tumorigenicity in Mice: A Preliminary Note,” J. Nat. Cancer Inst., 42, 1101-11149 1969.
Graham, S. L. et al., “Effects of Prolonged Ethylene Thiourea Ingestion on the Thyroid of the Rat, Food and Cosmetic Toxicology, 13, 493-499, 1975.
							
					
						Page last reviewed:  June 6, 2014					Content source: 	National Institute for Occupational Safety and Health homeNIOSH Publications & Products
NIOSH-Issued Publications
Search NIOSHTIC-2 Research Database
Docket
Documents for Public Review
Peer Review Agenda
Databases
eNews
Federal Register Noticesplus icon
FRN Archive 2007-2010
FRN Archive 2005-2006
FRN Archive 2001-2004
FRN Archive 1996-2000
Press Releases and Updatesplus icon
Press Release Archives 2010-2013
Press Release Archives 2006-2009
Press Release Archives 2001-2005
Press Release Archives 1998-2000
Press Release Archives 1992-1997
Regulations
Regulatory Agenda
Science Blog
Software
Video Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue